MedReleaf Corp. Opens the Market

Neil Closner, CEO, MedReleaf Corp. (LEAF), joined Richard Rohan, VP, Global Sales, Equity Capital Markets, Toronto Stock Exchange, to open the market. MedReleaf is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and an ICH-GMP and ISO 9001 certified medical cannabis producer. Sourced from around the world and operating in one of two facilities in Ontario, MedReleaf delivers a variety of products to patients seeking safe, consistent and effective medical cannabis. MedReleaf Corp. commenced trading on Toronto Stock Exchange on June 7, 2017. (CNW Group/TMX Group Limited)

TORONTO, June 23, 2017 /CNW/ - Neil Closner, CEO, MedReleaf Corp. (LEAF), joined Richard Rohan, VP, Global Sales, Equity Capital Markets, Toronto Stock Exchange, to open the market. MedReleaf is licensed by Health Canada under the Access to Cannabis for Medical Purposes Regulations (ACMPR), and an ICH-GMP and ISO 9001 certified medical cannabis producer. Sourced from around the world and operating in one of two facilities in Ontario, MedReleaf delivers a variety of products to patients seeking safe, consistent and effective medical cannabis. MedReleaf Corp. commenced trading on Toronto Stock Exchange on June 7, 2017.

SOURCE TMX Group Limited